The FDA recently granted EXG-34217 Rare Pediatric Disease Designation (RPDD) and Regenerative Medicine Advanced Therapy (RMAT) Designation.

Newborn testing has long-term heath outcomes, but legislative changes could affect newborn screening effectiveness.

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...

OKLAHOMA CITY, OKLAHOMA / ACCESS Newswire / February 20, 2025 / Xironetic announced today the publication of data from a recent study evaluating the potential benefits of augmented reality guidance wi ...

Dupuytren's contracture is a progressive hand condition affecting an estimated 17 million Americans, making it likely that most people know someone who has been impacted.

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

RIT graduate student Bryona Hamilton is creating an educational guide for cancer survivors about chemotherapy side effects ...